HuntsmanClariant deal continues to move forward
The United States Federal Trade Commission, which reviews the antitrust implications of certain business combinations, late Tuesday delivered a second request for information to the parties relating to just two products − sodium isethionate, used in personal care products like soap and shampoos, and a polyetheramine product used in certain construction and additive/paint and ink applications.
Closing around year-end
These products accounted for less than US-$24 million in total revenues of each of the two companies in the United States in 2016, and Clariant is confident that the parties will be able to satisfy any FTC concerns on a timeline consistent with the merger, which both companies continue to expect to close around year-end.